Willett C G, Suit H D, Tepper J E, Mankin H J, Convery K, Rosenberg A L, Wood W C
Department of Radiation Medicine, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Cancer. 1991 Jul 15;68(2):278-83. doi: 10.1002/1097-0142(19910715)68:2<278::aid-cncr2820680211>3.0.co;2-c.
From December 1981 to December 1989, 20 patients with primary or recurrent retroperitoneal sarcoma received 4000 to 5000 cGy of external beam radiation therapy (EBRT) in conjunction with surgical resection and intraoperative radiation therapy (IORT). Seventeen of 20 patients underwent complete (14 patients) or partial (3 patients) resection. Three patients had shown evidence of metastases after EBRT by the time of surgery. The 4-year actuarial local control and disease-free survival rates of the 17 patients undergoing resection were 81% and 64%, respectively. Twelve patients received IORT at the time of resection for microscopic disease (10 patients) or gross residual sarcoma (2 patients). Of the ten patients receiving IORT for microscopic tumor, one patient has died of local failure and peritoneal sarcomatosis and two patients have died of distant metastases only. The remaining seven patients are disease-free. One patient treated for gross residual sarcoma has experienced a local failure 1 year after IORT and is without disease 7 years after salvage chemotherapy. The other patient treated for gross residual sarcoma has died of local failure. Five patients did not receive IORT at the time of resection because of the extensive size of the tumor bed. Three of these patients are disease-free with one patient alive with lung metastases and one patient dying of hepatic metastases. Aggressive radiation and surgical procedures appear to provide satisfactory resectability and local control with acceptable tolerance.
1981年12月至1989年12月,20例原发性或复发性腹膜后肉瘤患者接受了4000至5000 cGy的外照射放疗(EBRT),并结合手术切除和术中放疗(IORT)。20例患者中有17例接受了根治性(14例)或部分性(3例)切除。3例患者在EBRT后手术时已出现转移迹象。17例接受切除的患者4年精算局部控制率和无病生存率分别为81%和64%。12例患者在切除时因微小病变(10例)或肉眼残留肉瘤(2例)接受了IORT。在10例因微小肿瘤接受IORT的患者中,1例死于局部复发和腹膜肉瘤病,2例仅死于远处转移。其余7例患者无病生存。1例因肉眼残留肉瘤接受治疗的患者在IORT后1年出现局部复发,在挽救性化疗后7年无病生存。另1例因肉眼残留肉瘤接受治疗的患者死于局部复发。5例患者因肿瘤床范围广泛在切除时未接受IORT。其中3例患者无病生存,1例患者带肺转移存活,1例患者死于肝转移。积极的放疗和手术操作似乎能提供令人满意的可切除性和局部控制,且耐受性可接受。